Published in J Mol Cell Immunol on January 01, 1987
Retracted Secretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A (1989) 1.44
Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade. Cancer Immunol Res (2015) 0.83
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst (2000) 6.38
Species Differentiation within the Genus Shigella by Test for Reduction of Trimethylamine Oxide. J Bacteriol (1944) 5.89
Hair analysis for drugs: technological break-through or ethical quagmire? Addiction (1993) 4.60
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol (1994) 4.37
Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol (1998) 3.95
Outbreak of HIV infection in a Scottish prison. BMJ (1995) 3.82
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell (1993) 3.80
Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am (2000) 3.37
Characteristics of human herpesvirus-6. J Infect Dis (1988) 3.02
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity (1994) 2.90
Widespread occurrence of avian spectrin in nonerythroid cells. Cell (1982) 2.90
The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med (1973) 2.68
Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J Sci Am (2006) 2.68
HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep (1997) 2.59
The Declaration of Helsinki and research in vulnerable populations. Med J Aust (2000) 2.41
Thymus-derived (T) cell immunoglobulins. Presence of a receptor site for IgG and absence of large amounts of "buried" Ig determinants on T cells. J Exp Med (1972) 2.35
Resident pulmonary lymphocytes expressing the gamma/delta T-cell receptor. Nature (1989) 2.16
The burden of disease in Maputo City, Mozambique: registered and autopsied deaths in 1994. Bull World Health Organ (2001) 2.11
Integrin alpha 2 beta 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol (1991) 2.08
Celiac disease and human leukocyte antigen genotype: accuracy of diagnosis in self-diagnosed individuals, dosage effect, and sibling risk. J Pediatr Gastroenterol Nutr (2000) 2.07
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol (1994) 2.07
Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature (1984) 2.02
In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol (1991) 2.00
Prophylactic use of cephazolin against wound sepsis after cholecystectomy. Br Med J (1977) 1.97
Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am (1998) 1.96
Synemin and vimentin are components of intermediate filaments in avian erythrocytes. J Cell Biol (1982) 1.94
The thymus has two functionally distinct populations of immature alpha beta + T cells: one population is deleted by ligation of alpha beta TCR. Cell (1989) 1.91
Diagnosis and management of 528 abdominal aortic aneurysms. Br Med J (Clin Res Ed) (1981) 1.89
Release and excretion of metal in patients who have a total hip-replacement component made of titanium-base alloy. J Bone Joint Surg Am (1991) 1.85
Studies on receptors for IgG on epithelial cells of the rat intestine. J Immunol (1977) 1.82
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol (1994) 1.80
Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci U S A (1974) 1.80
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today (1996) 1.79
Limited receptor repertoire in a mycobacteria-reactive subset of gamma delta T lymphocytes. Nature (1989) 1.77
Deep-vein thrombosis and pulmonary embolism. Lancet (1993) 1.73
Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am J Trop Med Hyg (1995) 1.69
Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice. Cell (1989) 1.66
Letter from Eritrea. Br Med J (Clin Res Ed) (1984) 1.65
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science (1992) 1.63
Influences of sensation seeking, gender, risk appraisal, and situational motivation on smoking. Addict Behav (1990) 1.59
Blindness following Haematemesis. Br Med J (1945) 1.57
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia. J Immunol (1974) 1.56
Local and distant products from modularity. Clin Orthop Relat Res (1995) 1.52
Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin. J Immunol (1977) 1.52
Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol (1996) 1.52
Regulation of catabolism of IgM heavy chains in a B lymphoma cell line. J Biol Chem (1982) 1.44
In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs. Transplantation (2001) 1.43
Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody. Cancer Res (1988) 1.43
Mixed infections with Plasmodium falciparum and P malariae and fever in malaria. Lancet (1994) 1.42
Determination of three-dimensional morphometry of adherent cells by surface profilometry. Biomaterials (1992) 1.42
Peptide sequences of T-cell receptor delta and gamma chains are identical to predicted X and gamma proteins. Nature (1988) 1.41
Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins. J Exp Med (1991) 1.39
Laparoscopic pericardial fenestration for malignant pericardial effusion. Lancet (1992) 1.39
Cobalt and chromium concentrations in patients with metal on metal total hip replacements. Clin Orthop Relat Res (1996) 1.38
Female genital mutilation: a contemporary issue, and a Victorian obsession. J R Soc Med (1997) 1.38
Diazoxide blood levels in man. J Pharm Sci (1967) 1.36
Results of Heller's operation for achalasia of the oesophagus. The importance of hiatal repair. Br J Surg (1976) 1.36
mu-Chains from a nonsecretor B cell line differ from secreted mu-chains at the C-terminal end. J Immunol (1978) 1.36
Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol (1995) 1.35
Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol (2001) 1.33
Several HLA alleles share overlapping peptide specificities. J Immunol (1995) 1.33
High speed synchrotron x-ray phase contrast imaging of dynamic material response to split Hopkinson bar loading. Rev Sci Instrum (2013) 1.33
Physical association of CD4 with the T cell receptor. J Immunol (1992) 1.28
Why do young infants fail to search for hidden objects? Cognition (1990) 1.28
Outlook for survivors of childhood in sub-Saharan Africa: adult mortality in Tanzania. Adult Morbidity and Mortality Project. BMJ (1996) 1.25
Macrophage/particle interactions: effect of size, composition and surface area. J Biomed Mater Res (1994) 1.22
Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J Immunol (1996) 1.21
Ruptured aortic aneurysms: postoperative complications and their aetiology. Br J Surg (1984) 1.21
In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res (2000) 1.20
Biochemical analysis of the modular enzyme inosine 5'-monophosphate dehydrogenase. Protein Expr Purif (1999) 1.18
Adenovirus infection of the cervix. Acta Cytol (1977) 1.17
High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J Virol Methods (1999) 1.17
Prevalence and clinical characteristics of celiac disease in Downs syndrome in a US study. Am J Med Genet (2001) 1.16
Nondrug treatment trials in psychophysiologic insomnia. Arch Intern Med (1995) 1.16
Moving cheaply: energetics of walking in the African elephant. J Exp Biol (1995) 1.15
Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol (1998) 1.15
Heterogeneity in lymphocyte spectrin distribution: ultrastructural identification of a new spectrin-rich cytoplasmic structure. J Cell Biol (1988) 1.14
Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta. J Exp Med (1991) 1.13
Health concerns of high school students and teachers' beliefs about student health concerns. Pediatrics (1988) 1.13
Alpha beta T cell receptor and CD3 transduce different signals in immature T cells. Implications for selection and tolerance. J Immunol (1989) 1.12
Natural history of adrenal haemorrhage in the newborn. Arch Dis Child (1973) 1.12
Significance of positive bacterial cultures from aortic aneurysm contents. Br J Surg (1985) 1.11
Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg Br (1994) 1.11
Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency. Cancer Res (1987) 1.10
Characterization of human ovarian carcinomas in a SCID mouse model. Gynecol Oncol (1999) 1.09
Development of FRP composite structural biomaterials: ultimate strength of the fiber/matrix interfacial bond in in vivo simulated environments. J Biomed Mater Res (1992) 1.08
A multicenter study of the treatment of non-union with constant direct current. J Bone Joint Surg Am (1981) 1.08
Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood (2001) 1.08
Development, application and validation of a Taqman real-time RT-PCR assay for the detection of infectious salmon anaemia virus (ISAV) in Atlantic salmon (Salmo salar). Dev Biol (Basel) (2006) 1.08
Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response. J Leukoc Biol (2000) 1.07
Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody. Cancer Res (1986) 1.07
Association of melanoma tumor antigen activity with beta2-microglobulin. Cancer Res (1979) 1.06
Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. J Immunol (1995) 1.06
Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. Proc Natl Acad Sci U S A (1985) 1.06
Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J Immunol (1997) 1.06
Retinal pigment epithelial wound healing in vivo. Arch Ophthalmol (1995) 1.05
A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther (1978) 1.05